Cooley LLP maintains a strong presence in the life sciences and healthcare sector, with particular emphasis on transactional work for startups and late-stage companies, including those pursuing IPOs. The firm regularly advises on securities offerings, joint ventures, and M&A matters involving life sciences businesses. Reston-based Christian Plaza serves as co-chair of the firm’s life sciences and healthcare vertical, alongside Marc Recht in Boston, who advises life sciences companies on capital markets transactions, joint ventures, and corporate deals. The firm has newly appointed Kenneth Krisko in Reston as head of corporate partnering and licensing, who is involved in significant life sciences commercial agreements. The team has recently expanded its regulatory, IP litigation, and non-IP litigation capabilities in support of its life sciences and healthcare client base. This combination of transactional strength and expanded advisory platforms is shown in the firm’s continued activity across multiple areas of the sector.
Legal 500 Editorial commentary

Key clients

  • Abivax
  • Acadia Pharmaceuticals
  • Autolus
  • Bicycle Therapeutics
  • Biomarin Pharmaceutical
  • Cidara Therapeutics
  • CG Oncology
  • Illumina
  • Inovio
  • Instil Bio
  • Jazz Pharmaceuticals
  • Liquidia Technologies

Work highlights

Advised BioNTechSE, on its $11.1 billion global co-development and co-commercialization collaboration agreement with Bristol Myers Squibb forBioNTech’s antibody candidate BNT327.
Advised Maplight Therapeutics, on its oversubscribed $372.5 million Series D crossover financing and subsequent $258.9 million IPO.
Advised Poseida Therapeutics, on its $1.5 billion sale to Roche.

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Christian Plaza
Christian Plaza
Marc Recht
Marc Recht
Practice head

Christian Plaza; Marc Recht; Kenneth Krisko